On Monday, Replimune Group Inc (NASDAQ: REPL) was -5.88% drop from the session before settling in for the closing price of $13.94. A 52-week range for REPL has been $4.92 – $17.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 15.48%. With a float of $61.36 million, this company’s outstanding shares have now reached $68.39 million.
Let’s look at the performance matrix of the company that is accounted for 331 employees. In terms of profitability, gross margin is 48.27%, operating margin of -5729.32%, and the pretax margin is -5260.12%.
Replimune Group Inc (REPL) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Replimune Group Inc stocks. The insider ownership of Replimune Group Inc is 18.55%, while institutional ownership is 81.83%. The most recent insider transaction that took place on Dec 16 ’24, was worth 124,200. In this transaction Chief Executive Officer of this company sold 10,000 shares at a rate of $12.42, taking the stock ownership to the 202,014 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Chief Strategy Officer proposed sale 15,000 for $12.57, making the entire transaction worth $188,550.
Replimune Group Inc (REPL) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.46% during the next five years compared to -19.52% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
You can see what Replimune Group Inc (REPL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -2.40 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Replimune Group Inc (NASDAQ: REPL) saw its 5-day average volume 0.56 million, a negative change from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 36.69%. Additionally, its Average True Range was 0.90.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 45.04%, which indicates a significant increase from 45.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.80% in the past 14 days, which was lower than the 76.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.68, while its 200-day Moving Average is $10.37. Nevertheless, the first resistance level for the watch stands at $13.71 in the near term. At $14.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.63. If the price goes on to break the first support level at $12.79, it is likely to go to the next support level at $12.45. Assuming the price breaks the second support level, the third support level stands at $11.87.
Replimune Group Inc (NASDAQ: REPL) Key Stats
There are 68,417K outstanding shares of the company, which has a market capitalization of 988.47 million. As of now, sales total 0 K while income totals -215,790 K. Its latest quarter income was 0 K while its last quarter net income were -53,060 K.
